M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' (ROSG) MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
Tweet Send to a Friend
Rosetta Genomics, Ltd. (NASDAQ: ROSG) announced today the initiation of a clinical validation study with The University ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
